CNST - Bought @ $34-MorphoSys (MOR) announced its $1.7 billion plan to acquire cancer treatment biotech Constellation Pharmaceuticals (CNST) on Wednesday and CNST stock rocketed to a four-month high.
-In morning trading on the stock market today, CNST stock soared 66.6% near 33.72.
-Under the terms of the deal, MorphoSys will pay $34 per share of CNST stock.
